EdgeScore

FLNA · Nasdaq

FILANA THERAPEUTICS, INC.: financial statements

Financially weak · see the checkFigures in USD, fiscal years

Revenue and net income

Revenue 2010: $16.8MNet income 2010: -$12.0M2010Revenue 2011: $11.5MNet income 2011: -$2.6M2011Revenue 2012: $10.9MNet income 2012: -$3.4M2012Revenue 2013: $41.1MNet income 2013: $31.5M2013
RevenueNet income

Operating and free cash flow

Operating cash flow 2010: -$143KFree cash flow 2010: -$143K2010Operating cash flow 2011: -$260KFree cash flow 2011: -$260K2011Operating cash flow 2012: -$7.2MFree cash flow 2012: -$7.2M2012Operating cash flow 2013: -$6.9MFree cash flow 2013: -$6.9M2013
Operating cash flowFree cash flow

Margins

Operating 2010: -81.5%Operating 2011: -30.6%Operating 2012: -35.8%Operating 2013: 76.3%Net 2010: -71.5%Net 2011: -22.8%Net 2012: -31.6%Net 2013: 76.7%2010201120122013
GrossOperatingNet

Returns

ROE 2010: -36.5%ROE 2011: -5.9%ROE 2012: -26.2%ROE 2013: 65.3%ROIC 2010: -38.5%ROA 2010: -12.1%ROA 2011: -2.6%ROA 2012: -6.1%ROA 2013: 63.0%2010201120122013
ROEROICROA

Income statement

USD2010201120122013Last year
Revenue$16.8M$11.5M$10.9M$41.1M+278%
Operating income-$13.7M-$3.5M-$3.9M$31.4M+905%
EBITDA-$13.5M-$3.4M-$3.8M$31.4M+931%
Profit before tax-$12.0M-$2.6M-$3.4M$31.5M+1013%
Income tax—$0$0-$73.0K
Net income-$12.0M-$2.6M-$3.4M$31.5M+1015%

Cash flow

USD2010201120122013Last year
Operating cash flow-$143K-$260K-$7.2M-$6.9M+3%
Free cash flow-$143K-$260K-$7.2M-$6.9M+3%
Depreciation & amortization$232K$163K$122K—

Balance sheet

USD2010201120122013Last year
Cash$4.8M$73.1M$49.4M$48.6M-2%
Current assets$98.5M$98.5M$56.5M$50.1M-11%
Total assets$99.2M$99.0M$56.9M$50.1M-12%
Current liabilities$14.1M$13.3M$10.0M$1.8M-82%
Total liabilities$66.3M$54.6M$43.7M$1.8M-96%
Shareholders' equity$32.9M$44.4M$13.1M$48.3M+268%
Net debt-$4.8M-$73.1M-$49.4M-$48.6M+2%

Ratios

2010201120122013Last year
Operating margin-81.5%-30.6%-35.8%76.3%
Net margin-71.5%-22.8%-31.6%76.7%
Return on equity-36.5%-5.9%-26.2%65.3%
Return on assets-12.1%-2.6%-6.1%63.0%
Return on invested capital-38.5%———
Net debt / EBITDA———-1.5x
Current ratio7.007.425.6527.82
Quick ratio7.007.425.6527.82

Data source: SEC EDGAR, company annual reports. Lines a company does not report are left empty. Free cash flow is operating cash flow minus capital expenditure. Ratios use the same formulas as the EdgeScore check.

For information and education only. Not investment advice. Data may contain errors.